Влияние недостаточности α1-антитрипсина на поражение легких


Полный текст:

Об авторах

С. И. Овчаренко
ГОУ ВПО "Первый Московский государственный медицинский университет им. И.М.Сеченова"

д. м. н., проф. кафедры факультетской терапии № 1 лечебного факультета 

119991, Москва, ул. Большая Пироговская, 6. Тел.: (499) 248-56-67.

Е. А. Сон
ГОУ ВПО "Первый Московский государственный медицинский университет им. И.М.Сеченова"

к. м. н., ассистент кафедры факультетской терапии № 1 лечебного факультета

119991, Москва, ул. Большая Пироговская, 6. Тел.: (499) 248-55-24.

Список литературы

1. Travis J., Salvesen G.S. Human plazma proteinase inhibitors. Ann. Rev. Biochem. 1983; 52: 655–709.

2. Sandhaus R.A. Elastase may play a central role in the neutrophil migration through connective tissue. In: Taylor J.C., Mittman C., eds. Pulmonary emphysema and proteolysis. Orlando F.L: Academic Press; 1997. 227–233.

3. Пузырев В.П., Огородова Л.М. (ред.). Генетика бронхолегочных заболеваний. (Серия монографий Российского респираторного общества; гл. ред. Чучалин А.Г.). М.: Атмосфера; 2010.

4. Bulletin of the World Health Organization. 1997; 75 (5): 397–415.

5. Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am. J. Respir. Crit. Care Med. 2003; 168: 818–900.

6. Kamboh M.I. Biochemical and genetic aspects of human serum α1-proteinase inhibitor protein. Dis. Markers 1985; 3: 135.

7. Ogushi F., Fells G.A., Hubbard R.C. et al. Z-type α1-antitrypsin in less competent then M1-type α1-antitrypsin as an inhibitor of neutrophil elastase. J. Clin. Invest. 1987; 80: 1366–1374.

8. Owen M.C., Brennan S.O., Lewis J.H., Carrell R.W. Mutation of antitrypsin to antithrombin α1 antitrypsin Pittsburgh (358-Met->Arg), a fatal bleeding disorder. N. Engl. J. Med. 1983; 309: 694–698.

9. Laurell C.B., Eriksson S. The electrophoretic pattern alpha-1-globulin pattern of serum in alpha l-antitrypsin deficiency. Scan. J. Clin. Lab. Invest. 1963; 15: 132–140.

10. Crystal R.G. Alpha-1 antitrypsin deficiency, emphysema and liver disease: genetic basis and strategies for therapy. J. Clin. Invest. 1998; 85: 1343–1352.

11. Gadek J.E., Fells G.A., Zimmerman R.L. et al. Anti-elastase of the human alveolar structures: implications for the protease-antiprotease theory of emphysema. J. Clin. Invest. 1981; 68: 889–898.

12. Svegar T., Piitulainen E., Arborelius M. Jr. Lung function in adolescents with alpha-1-antitrypsin deficiency. Acta. Paediatr. 1994; 83: 1170–1193.

13. Brantly M.L., Paul L.D., Miller B.H. et al. Clinical features and history of the destructive lung disease associated with alpha-1 antitrypsin deficiency of adults with pulmonary symptoms. Am. Rev. Respir. Dis 1988; 138: 327–336.

14. Seersholm N., Kok-Jensen A., Dirksen A. Survival of patients with severe α1-antitrypsin deficiency with special reference to non-index cases. Thorax 1994; 49: 695–698.

15. Piitulainen E., Torning G., Eriksson S. Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with α1-antitrypsin deficiency (PI*ZZ). Thorax 1997; 52: 244–248.

16. Piitulainen E., Torning G., Eriksson S. Environmental correlates of impaired lung function in non-smokers with severe α1 antitrypsin deficiency (PI*ZZ). Thorax 1998; 53: 939–943.

17. Brandslund I., Lund E.D., Sigsgaard T. Is a low serum concentration of α1-antitrypsin associated with an increased susceptibility for byssinosis in cotton mill workers? Considerations regarding analytical quality reguirements and economical consequences. Ups. J. Med. Sci. 1993; 98: 299–310.

18. Sigsgaard T., Brandslund I., Rasmussen J.B. et al. Low normal α1-antitrypsin serum concentration and MZ-phenotype are associated with byssinosis and familial allergy in cotton mill workers. Pharmacogenetics 1994; 4: 135–141.

19. Home S.L., Tennent R.K., Cockcroft D.W. et al. Pulmonary function in PiM and MZ grainworkers. Chest 1986; 89: 795–799.

20. Pierre F., Pham Q.T., Mur J.M. et al. Respiratory symptoms and function in 871 miners according to Pi phenotype: a longitudinal study. Eur. J. Epidemiol. 1988; 4: 39–44.

21. Larsson С. Natural history and life expectancy in severe α1 antitrypsin deficiency, PiZ. Acta. Med. Scand. 1978; 204: 345–351.

22. Osman M., Cantor J.O., Roffman S. et al. Cigarette smoke impairs elastin resynthesis in lungs of hamsters with elastase-induced emphysema. Am. Rev. Respir. Dis. 1985; 132: 640–643.

23. Hautamaki R.D., Kobayashi D.K., Senior R.M., Shapiro S.D. Requirement for macrophage elastase for cigarette smokeinduced emphysema in mice. Science 1997; 277: 2002–2004.

24. Morrison H.M., Kramps J.A., Burnett D., Stockley R.A. Lung lavage fluid from patients with α1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile. Clin. Sci. 1987; 72: 373–381.

25. Eriksson S. Studies in α1-antitrypsin deficiency. Acta. Med. Scand. 1965; 432: 1–85.

26. Tobin M.J., Cook P.J.L., Hutchinson D.C.S. Alpha-1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. Br. J. Dis. Chest 1983; 77: 14–27.

27. Janus E.D., Phillips N.T., Carrel R.W. Smoking, lung function and – α1-antitrypsin deficiency. Lancet 1985; 1: 152–154.

28. Rawlings W. Jr., Kreiss P., Levy D. et al. Clinical, epidemiological and pulmonary function studies in alpha-1 antitrypsin deficiency subjects of PI*ZZ type. Am. Rev. Respir. Dis. 1976; 114: 945–953.

29. McElvaney N.G., Stoller J.K., Buist A.S. et al. Alpha-1 Antitrypsin Deficiency Study Group. Baseline characteristics of enrolles in the National Heart, Lung, and Blood Institute Registry of α1-Antitrypsin deficiency. Chest 1997; 111: 394–403.

30. Eden E., Mitchell D., Mehlmann B. et al. Atopy, asthma and emphysema in patients with severe α1-antitrypsin deficiency. Am. J. Respir. Crit. Care Med. 1997; 156: 68-74.

31. King M.A., Stone J.A., Diaz P.T. et al. Alpha-1 antitrypsin deficiency: evaluation of bronchiectasis with CT. Radiology 1996; 199: 137–141.

32. Guest P.J., Hansell D.M. High resolution computed tomography (HRCT) in emphysema associated with alpha-1 antitrypsin deficiency. Clin. Radiol. 1992; 45: 260–266.

33. Cuvelier A., Muir J.F., Hellot M.F. et al. Distribution of alpha-1-antitrypsin alleles in patients with bronchiectasis. Chest 2000; 117: 415–419.

34. Bienert T., Brand P., Behr J. et al. Peripheral airspace dimensions in patients with COPD. Chest 1995; 108: 998–1003.

35. Foster W.L., Gimenez E.I., Roubidoux M.A. et al. The emphysema: radiologic-pathologic correlations. Radiographics 1993; 13: 311–328.

36. Gishen P., Saunders A.J.S., Tobin M.J., Hutchison D.C.S. Alpha-1 antitrypsin deficiency: the radiological features of pulmonary emphysema in subjects of Pi-type-Z and Pi-type SZ. A survey by the British Thoracic Association. Clin. Radiol. 1982; 33: 371–377.

37. Guenter C.A., Welch M.H., Russel T.R. et al. The pattern of lung disease assosiated with alpha-1 antitrypsin deficiency. Arch. Intern. Med. 1968; 122: 254–257.

38. Wilson J.S., Galvin J.R. Normal diffusing capacity in patients with PiZ alpha-1-antitrypsin deficiency, severe airflow obstruction, and significant radiographic emphysema. Chest 2000; 118: 867–871.

39. Schwaiblmair M., Beinert T., Seemann M. et al. Relations between cardiopulmonary execise testing and quantitative high-resolution computed tomography associated in patients with alpha-1-antitrypsin deficiency. Eur. J. Med. Res. 1998; 3: 527–532.

40. Miller R.R., Muller N.L., Vedal S. et al. Limitations of computed tomography in the assessment of emphysema. Am. Rev. Respir. Dis. 1989; 139: 980–983.

41. Flenley D.C. Diagnosis and follow-up of emphysema. Eur. Respir. Suppl. 1998; 9: 5s–8s.

42. Biernacki W., Ryan M., MacNee W., Flenley D.C. Can the quantitative CT scan detect progression of emphysema? [abstract] Am. Rev. Respir. Dis. 1989; 131: A120.

43. Seersholm N., Kok-Jensen A. Survival in relation to lung function and smoking cassation of patients with severe hereditary α1-antitrypsin deficiency. Am. J. Respir. Crit. Care Med. 1995; 151: 369–373.

44. Enright P.L., Connet J.E., Kanner R.E. et al. Spirometry in the Lung Health Study. II. Determinants of short-term intraindividual variability. Am. J. Respir. Crit. Care Med. 1995; 151: 406-411.

45. Dirksen A., Holstein-Rathlou N.-H., Madsen F. et al. Long range correlations of serial FEV1 measurements in emphysematous and normal subjects. J. Appl. Physiol. 1998; 85: 259–265.

46. Hutchison D.C., Tobin M.J., Cooper D., Lowe D. Longitudinal studies in α1-antitrypsin deficiency: a survey by the British Thoracic Society. In: Taylor J.C., Mittman C., eds. Pulmonary emphysema and proteolysis. Orlando F.L.: Academic Press; 1987.

47. Buist A.S., Burrows B., Eriksson S. et al. The natural history of air-flow obstruction in PiZ emphysema: report of an NHLBI workshop. Am. Rev. Respir. Dis. 1983; 127: S43–S45.

48. Seersholm N., Kok-Jensen A., Dirksen A. Decline in FEV1 among patients with severe hereditary α1-antitrypsin type PiZ. Am. J. Respir. Crit. Care Med. 1995; 152: 1922–1925.

49. McElvaney N.G., Crystal R.D. Clinical manifestation of α1-antitrypsin deficiency. In: Crystal RD, ed. Lung Biology in Health and Disease, Vol.88: α1-antitrypsin deficiency. New York: Marcel Dekker; 1996.

50. Teckman J.H., Qu D., Perlmutter D.H. Molecular pathogenesis of liver disease in α1-antitrypsin deficiency. Hepatology 1996; 24: 1504–1516.

51. Marcus N., Teckman J.H., Perlmutter D.H. Alpha-1 antitrypsin deficiency: from genotype to childhood disease. J. Pediatr. Gastroenterol. Nutr. 1998; 27: 65–74.

52. Sharp H.L. α1-antitrypsin deficiency. Hosp. Pract. 1971; 6: 83-96.

53. Migliazza L., Lopez S.M., Murcia J. et al. Long-term survival expectancy after liver transplantation in children. J. Pediatr. Surg. 2000; 35: 7–8.

54. Savige J.A., Chang L., Cook L. et al. Alpha1-antitrypsin deficiency and anti-proteinase 3 antibodies in antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin. Exp. Immunol. 1995; 100: 194–197.

55. Esnault V.L.M., Audrain M.A.P., Sesboüè R. Alpha-1 antitrypsin phenotyping in ANCA-associated diseases: one of several arguments for protease / antiprotease imbalance in systemic vasculitis. Exp. Clin. Immunogenet. 1997; 14: 206–213.

56. Segelmark M., Elzouki A.N., Wieslander J., Eriksson S. The PiZ gene of alpha1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int. 1995; 48: 844–850.

57. World Health Organization. Alpha1-antitrypsin deficiency: memorandum from a WHO meeting. Bull. World Health Organ. 1997; 75: 397–415.

58. Smith К.С., Su W.P.D., Pittelkow M.R., Winkelmann R.K. Clinical and pathologic correlations in 96 patients with panniculitis, including 15 patients with deficient levels of alpha1-antitrypsin. J. Am. Acad. Dermatol. 1989; 21: 1192–1196.

59. Lung Health Study. Effects of smoking intervention and use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. J.A.M.A. 1994; 272: 1497–1505.

60. American Thoracic Society (Medical Section of the American Lung Association). Pulmonary rehabilitation-1999. Am. J. Respir. Crit. Care Med. 1999; 159: 1666–1682.

61. Kojalima H., Geddes D.M. Erythromycin in diffuse panbronchiolitis. Thorax 1997; 52: 915–918.

62. Wilcke J.T., Dirksen A. The effect of inhaled glucocorticosteroids in emphysema due to α1-antitrypsin deficiency. Respir. Med. 1997; 9: 275–279.

63. Schwaibmaier M., Vogelmeier С. Alpha-1-antitrypsin: hope on the horizon for emphysema sufferers. Drug Ther. (NY) 1998; 12: 429–440.

64. Wencker M., Banik N., Buhl R., Konietzko N. Long-term treatment of α1 antitrypsin deficiency-related pulmonary emphysema with human α1-antitrypsin. Eur. Respir. J. 1998; 11: 428–433.

65. Seersholm N., Wencker M., Banik N. et al. Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Eur. Respir. J. 1997; 10: 2260–2263.

66. Dirksen A., Dijkman J.H., Madsen F. et al. A randomized clinical trial of α1-antitrypsin augmentation therapy. Am. J. Respir. Crit. Care Med. 1999; 160: 1468–1472.

67. Hosenpud J.D., Novick R.J., Breen T.J. et al. Registry of the International Society for Heart and Lung Transplantation: twelfth official report. J. Heart Lung Transplant. 1995; 14: 805–815.

68. Cassina P.C., Teschler H., Konietzko N. et al. Two-year results after lung volume reduction surgery in α1-antitrypsin deficiency versus smoker's emphysema. Eur. Respir. J. 1998; 12: 1028–1032.

Дополнительные файлы

Для цитирования: Овчаренко С.И., Сон Е.А. Влияние недостаточности α1-антитрипсина на поражение легких.  Пульмонология. 2011;(5):79-86. https://doi.org/10.18093/0869-0189-2011-0-5-79-86

For citation: Ovcharenko S.I., Son E.A. Effects of alfa-1-antitripsin deficiency on lung disease. Russian Pulmonology. 2011;(5):79-86. (In Russ.) https://doi.org/10.18093/0869-0189-2011-0-5-79-86

Просмотров: 249

Обратные ссылки

  • Обратные ссылки не определены.

ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)